Thrombin inhibitors in unstable angina: Rebound or continuation of angina after argatroban withdrawal?
- 30 April 1993
- journal article
- editorial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 21 (5), 1048-1051
- https://doi.org/10.1016/0735-1097(93)90223-n
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectorisJournal of the American College of Cardiology, 1993
- Effects of aspirin on coronary reocclusion and recurrent ischemia after thrombolysis: A meta-analysisJournal of the American College of Cardiology, 1992
- The Current Role of Platelet-Active Drugs in Ischaemic Heart DiseaseDrugs, 1991
- Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury.JCI Insight, 1989
- Aspirin, Heparin, or Both to Treat Acute Unstable AnginaNew England Journal of Medicine, 1988
- Thrombin‐Cellular InteractionsAnnals of the New York Academy of Sciences, 1986
- Aspirin, Sulfinpyrazone, or Both in Unstable AnginaNew England Journal of Medicine, 1985
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983
- Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805. The importance of stereo-structure of its hydrophobic carboxamide portionBiochemical and Biophysical Research Communications, 1981
- TRIAL OF HEPARIN VERSUS ATENOLOL IN PREVENTION OF MYOCARDIAL INFARCTION IN INTERMEDIATE CORONARY SYNDROMEThe Lancet, 1981